Related Experiment Video
Updated: Aug 6, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
G2 cell cycle arrest and cyclophilin A in lentiviral gene transfer
Shangming Zhang1, Guiandre Joseph, Karen Pollok
1Department of Medical and Molecular Genetics, Indiana University School of Medicine, 975 West Walnut Street, Indianapolis, IN 46202, USA.
Abstract:
Lentiviral vectors derived from the human immunodeficiency virus-1 (HIV-1) have a higher propensity to transduce nondividing cells compared to vectors based on oncoretroviruses. We report here that genistein, a previously known protein tyrosine kinase (PTK) inhibitor and G2 cell cycle arrest inducer, significantly enhanced lentiviral transduction in a dose-dependent manner. Increased transduction, as measured by vector expression, was seen in a variety of human cell lines, murine primary lymphocytes, and primary human CD34(+) peripheral blood progenitor cells as well. Increased vector expression was also associated with an increase in vector DNA copy number, as assessed by quantitative PCR. Genistein-mediated G2 cell cycle arrest, rather than PTK inhibition, appears to be the major factor responsible for increased gene transfer. Genistein also increases cyclophilin A (CypA) protein, a cellular protein important for efficient HIV-1 infection. While we show that CypA(-/-) Jurkat cells transduce poorly with lentiviral vectors, genistein does increase gene transfer in CypA-deficient cells. CypA and G2 cell cycle arrest appear to be two independent factors important for efficient lentiviral gene transfer. The role of genistein and other G2-arresting agents may be useful for improving the efficiency of lentiviral gene therapy.
Insights
Genistein enhances lentiviral vector transduction by inducing G2 cell cycle arrest and increasing cyclophilin A, improving gene therapy efficiency.
Area of Science:
- Molecular Biology
- Gene Therapy
- Virology
Background:
- Lentiviral vectors, derived from human immunodeficiency virus-1 (HIV-1), efficiently transduce nondividing cells.
- Enhancing lentiviral transduction is crucial for improving gene therapy efficacy.
Purpose of the Study:
- To investigate the effect of genistein on lentiviral vector transduction.
- To determine the mechanisms underlying genistein-mediated enhancement of gene transfer.
Main Methods:
- Assessed lentiviral transduction efficiency in various human and murine cell lines using genistein.
- Measured vector expression and vector DNA copy number via quantitative PCR.
- Investigated the roles of G2 cell cycle arrest and cyclophilin A (CypA) in genistein's effect.
Main Results:
- Genistein significantly enhanced lentiviral transduction in a dose-dependent manner across multiple cell types.
- Increased transduction correlated with higher vector DNA copy number.
- Genistein-mediated G2 cell cycle arrest was identified as the primary driver of enhanced gene transfer, independent of protein tyrosine kinase (PTK) inhibition.
- Genistein also increased cyclophilin A (CypA) levels, another factor important for lentiviral infection.
Conclusions:
- Genistein effectively improves lentiviral gene transfer efficiency.
- Both G2 cell cycle arrest and increased CypA are independent factors promoting lentiviral transduction.
- Genistein and other G2-arresting agents hold promise for advancing lentiviral gene therapy.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System
Positive Regulator Molecules
DNA Damage can Stall the Cell Cycle

